LiveCare Past Earnings Performance
Past criteria checks 0/6
LiveCare's earnings have been declining at an average annual rate of -25.8%, while the Pharmaceuticals industry saw earnings growing at 2.1% annually. Revenues have been growing at an average rate of 182.9% per year.
Key information
-25.8%
Earnings growth rate
8.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 182.9% |
| Return on equity | n/a |
| Net Margin | -288.3% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How LiveCare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 4 | -10 | 2 | 0 |
| 31 Mar 23 | 3 | -11 | 3 | 0 |
| 31 Dec 22 | 3 | -12 | 4 | 0 |
| 30 Sep 22 | 2 | -10 | 3 | 0 |
| 30 Jun 22 | 1 | -8 | 2 | 0 |
| 31 Mar 22 | 1 | -9 | 2 | 0 |
| 31 Dec 21 | 0 | -9 | 3 | 0 |
| 30 Sep 21 | 0 | -10 | 5 | 0 |
| 30 Jun 21 | 0 | -12 | 8 | 0 |
| 31 Mar 21 | 0 | -10 | 6 | 0 |
| 31 Dec 20 | 0 | -7 | 4 | 0 |
| 30 Sep 20 | 0 | -5 | 2 | 0 |
| 30 Jun 20 | 0 | -2 | 1 | 0 |
| 31 Mar 20 | 0 | -2 | 1 | 0 |
Quality Earnings: LVCE is currently unprofitable.
Growing Profit Margin: LVCE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if LVCE's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare LVCE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LVCE is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).
Return on Equity
High ROE: LVCE's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.